Gregory Mishkel
About
Gregory Mishkel is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Gregory Mishkel has authored 49 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cardiology and Cardiovascular Medicine, 32 papers in Surgery and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gregory Mishkel's work include Coronary Interventions and Diagnostics (24 papers), Cardiac Valve Diseases and Treatments (13 papers) and Cardiac Imaging and Diagnostics (11 papers). Gregory Mishkel is often cited by papers focused on Coronary Interventions and Diagnostics (24 papers), Cardiac Valve Diseases and Treatments (13 papers) and Cardiac Imaging and Diagnostics (11 papers). Gregory Mishkel collaborates with scholars based in United States, Canada and New Zealand. Gregory Mishkel's co-authors include Donald E. Cutlip, Barry T. Katzen, Pierre Fayad, Neil E. Strickman, Jay S. Yadav, Tanvir Bajwa, Jeffrey J. Popma, Patrick L. Whitlow, Richard E. Kuntz and Michael R. Jaff and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.
In The Last Decade
Gregory Mishkel
49 papers receiving 3.9k citations
Hit Papers
Peers
Gregory Mishkel
P.A. Gaines United Kingdom
Tanvir Bajwa United States
Heather Meldrum Canada
R.G.A. Ackerstaff Netherlands
Paola De Rango Italy
William C. Mackey United States
Gary M. Ansel United States
Alberto Cremonesi Italy
Gianmarco de Donato Italy
Ramazanali Ahmadi Austria
Citations per year, relative to Gregory Mishkel Gregory Mishkel (= 1×)
peers
P.A. Gaines
Countries citing papers authored by Gregory Mishkel
Since
Specialization
Citations
This map shows the geographic impact of Gregory Mishkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Mishkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Mishkel more than expected).
Fields of papers citing papers by Gregory Mishkel
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Gregory Mishkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Mishkel. The network helps show where Gregory Mishkel may publish in the future.
Co-authorship network of co-authors of Gregory Mishkel
This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Mishkel. A scholar is included among the top collaborators of Gregory Mishkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Mishkel. Gregory Mishkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Mukherjee, Debabrata, Simon Dixon, Vardhmaan Jain, et al.. (2022). P2Y12 inhibitor versus aspirin monotherapy for secondary prevention of cardiovascular events: meta-analysis of randomized trials. European Heart Journal Open. 2(2). oeac019–oeac019.
2.
Mehta, Minesh P., Thomas Nolte, Gregory Mishkel, et al.. (2013). One-year outcomes from an international study of the Ovation Abdominal Stent Graft System for endovascular aneurysm repair. Journal of Vascular Surgery. 59(1). 65–73.e3.
3.
Ormiston, John A., Tift Mann, Jack Hall, et al.. (2012). Final 5-year results of the TAXUS ATLAS, TAXUS ATLAS Small Vessel, and TAXUS ATLAS Long Lesion clinical trials of the TAXUS Liberté paclitaxel-eluting stent in de-novo coronary artery lesions. Coronary Artery Disease. 24(1). 61–68.
4.
Sick, Peter, Zoltan G. Turi, Eberhard Grube, et al.. (2011). STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION: LONG-TERM RESULTS AFTER 6 YEARS OF THE WATCHMAN LEFT ATRIAL APPENDAGE OCCLUSION PILOT STUDY. Journal of the American College of Cardiology. 57(14). E1999–E1999.
5.
Weissman, Neil J., Mark Turco, John A. Ormiston, et al.. (2010). Improved strut coverage and less late incomplete apposition with thin-strut TAXUS Liberté vs. TAXUS Express: the importance of stent platform design for drug-eluting stents. Cardiovascular revascularization medicine. 12(4). 247–257.
6.
Goswami, Nilesh, et al.. (2009). Long‐term outcomes of drug‐eluting stents versus bare‐metal stents in saphenous vein graft disease: Results from the Prairie “Real World” Stent Registry. Catheterization and Cardiovascular Interventions. 75(1). 93–100.
7.
Turco, Mark, John A. Ormiston, Jeffrey J. Popma, et al.. (2008). Reduced Risk of Restenosis in Small Vessels and Reduced Risk of Myocardial Infarction in Long Lesions With the New Thin-Strut TAXUS Liberté Stent. JACC: Cardiovascular Interventions. 1(6). 699–709.
8.
Mishkel, Gregory, et al.. (2008). Correlates of late and very late thrombosis of drug eluting stents. American Heart Journal. 156(1). 141–147.
9.
Sick, Peter, Gerhard Schüler, Karl Eugen Hauptmann, et al.. (2007). Initial Worldwide Experience With the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Atrial Fibrillation. Journal of the American College of Cardiology. 49(13). 1490–1495.
10.
Moses, Jeffrey W., Giora Weisz, Gregory Mishkel, et al.. (2007). The SIRIUS‐DIRECT trial: A multi‐center study of direct stenting using the sirolimus‐eluting stent in patients with de novo native coronary artery lesions. Catheterization and Cardiovascular Interventions. 70(4). 505–512.
11.
Weisz, Giora, Jeffrey W. Moses, Paul S. Teirstein, et al.. (2007). Safety of Sirolimus-Eluting Stenting and Its Effect on Restenosis in Patients With Unstable Angina Pectoris (a SIRIUS Substudy). The American Journal of Cardiology. 99(8). 1044–1050.
12.
Mishkel, Gregory, et al.. (2006). Long-Term Outcomes After Management of Restenosis or Thrombosis of Drug-Eluting Stents. Journal of the American College of Cardiology. 49(2). 181–184.
13.
Hirohata, Atsushi, Yoshihiro Morino, Junya Ako, et al.. (2006). Comparison of the Efficacy of Direct Coronary Stenting With Sirolimus-Eluting Stents Versus Stenting With Predilation by Intravascular Ultrasound Imaging (from the DIRECT Trial). The American Journal of Cardiology. 98(11). 1464–1467.
14.
Nikolsky, Eugenia, Edward Kosinski, Gregory Mishkel, et al.. (2005). Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial). The American Journal of Cardiology. 95(6). 709–715.
15.
Stone, Gregg W., Paul S. Teirstein, Ronald C. Rubenstein, et al.. (2002). A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions. Journal of the American College of Cardiology. 39(10). 1581–1587.
16.
Lucore, Charles L., Gregory Mishkel, Krishna J. Rocha‐Singh, et al.. (2001). Impact of abciximab and coronary stenting on outcomes and costs of percutaneous coronary interventions in a community hospital. Coronary Artery Disease. 12(2). 135–142.
17.
Mishkel, Gregory, Frank V. Aguirre, Robert W. Ligon, Krishna J. Rocha‐Singh, & Charles L. Lucore. (1999). Clopidogrel as adjunctive antiplatelet therapy during coronary stenting. Journal of the American College of Cardiology. 34(7). 1884–1890.
18.
Lucore, Charles L., Gregory Mishkel, Robert W. Ligon, & Krishna J. Rocha‐Singh. (1999). Economic implications of coronary stenting with adjunctive IIb/IIIa receptor antagonists in a community hospital.. PubMed. 11 Suppl C. 14C–20C.
19.
Mickleborough, Lynda L., Gregory J. Wilson, Gregory Mishkel, et al.. (1989). A Simplified Concept for a Bileaflet Atrioventricular Valve that Maintains Annular-Papillary Muscle Continuity. Journal of Cardiac Surgery. 4(1). 58–68.
20.
Turpie, Alexander G.G., John G. Robinson, D. John Doyle, et al.. (1989). Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction. New England Journal of Medicine. 320(6). 352–357.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by P.A. Gaines Breakdown of academic impact, for papers by Tanvir Bajwa Breakdown of academic impact, for papers by Heather Meldrum Breakdown of academic impact, for papers by R.G.A. Ackerstaff Breakdown of academic impact, for papers by Paola De Rango Breakdown of academic impact, for papers by William C. Mackey Breakdown of academic impact, for papers by Gary M. Ansel Breakdown of academic impact, for papers by Alberto Cremonesi Breakdown of academic impact, for papers by Gianmarco de Donato Breakdown of academic impact, for papers by Ramazanali Ahmadi